Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NexGen Medical Systems was a medical technology company specializing in the development of advanced nitinol stent systems for interventional procedures. Based in Eagan, Minnesota, the company's primary product was the X-Suit, a self-expanding nitinol stent designed for the treatment of biliary obstructions and other vascular conditions. The company's technology focused on optimizing stent flexibility and radial strength through proprietary nitinol designs. In May 2014, NexGen Medical Systems was acquired by Vascular Solutions for an initial cash payment of $2 million plus future royalties. Following the acquisition of Vascular Solutions by Teleflex in 2017, NexGen's assets and intellectual property were integrated into the Teleflex interventional vascular portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NexGen Medical Systems.